Health Care Archives - Page 462 of 478

1 minute read

Despite Capital Budget Softness, Long Term Opportunity Remains Intact For Intuitive Surgical: Raymond James Analyst

July 22, 1:44 PM

Yesterday, Intuitive Surgical Inc (NASDAQ:ISRG) reported lower-than-expected Q2 earnings. Raymond James writes, “we were worried about the capital equipment environment, we admittedly…

ISRG

1 minute read

FDA Clears iRhythm’s ZEUS System For Zio Watch Made In Partnership With Google’s Verily

By Vandana Singh

July 22, 10:55 AM

iRhythm Technologies Inc (NASDAQ:IRTC) has received FDA 510(k) clearance for its ZEUS (Zio ECG Utilization Software) System for the Zio Watch. …

GOOG

1 minute read

VistaGen Says Data From Late-Stage Anxiety Study ‘Not Consistent’ With Prior Positive Phase 2 Study

By Vandana Singh

July 22, 9:06 AM

VistaGen Therapeutics Inc (NASDAQ:VTGN) has announced topline results from its PALISADE-1 Phase 3 trial of PH94B for the acute treatment of…

VTGN

1 minute read

Bavarian Nordic’s Monkeypox Vaccine Gets Thumbs Up From EU Regulator

By Vandana Singh

July 22, 7:31 AM

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a “positive opinion” recommending Bavarian Nordic…

BVNKF

1 minute read

Liminal BioSciences Pulls Plug On Its Lead Development Program

By Vandana Singh

July 22, 6:54 AM

Liminal BioSciences Inc (NASDAQ:LMNL) will discontinue the development of fezagepras based on results from the Phase 1a single ascending dose (SAD)…

LMNL

1 minute read

Tenet Healthcare Posts Lower Sales, Profits On Unfavorable Impact Of Cyber Attack

By Vandana Singh

July 22, 6:06 AM

Tenet Healthcare Corp’s (NYSE:THC) Q2 FY22 adjusted EPS came in at $1.50, down from $1.59 a year ago and beating…

THC

2 minute read

Amazon’s On-Again, Off-Again Big Bets On Health Care Sector

By AJ Fabino

July 21, 6:18 PM

In its most recent entry into the health care industry, Amazon.com, Inc.

AMZN

1 minute read

With All Eyes On Lecanemab Read Out In Alzheimer’s, Uncertainty Overshadows Biogen’s Q2 Beat

By Vandana Singh

July 21, 3:44 PM

Yesterday, Biogen Inc (NASDAQ:BIIB) reported Q2 earnings. Needham writes that while operational performance looked good, uncertainty looms over the company’s growth potential. Lecanemab Phase…

BIIB

1 minute read

This Analyst Says Invitae’s Current Valuation ‘Not Accommodative’

By Vandana Singh

July 21, 3:28 PM

Raymond James has downgraded Invitae Corp (NYSE:NVTA) to Market Perform from Outperform following news of a full reset, including leadership changes…

NVTA

1 minute read

HC Wainwright Starts Coverage On This ‘Best-In-Class Agent For Inflammatory Disorders

By Vandana Singh

July 21, 1:01 PM

HC Wainwright initiated coverage on MoonLake Immunotherapeutics (NASDAQ:MLTX) with a Buy rating and a price target of $28, citing a potentially best-in-class…

MLTX